Article
The dopamine b-hydroxylase 19 bp insertion/deletion polymorphism was associated with first-episode but not medicated chronic schizophrenia.
Journal of psychiatric research - 1 Jun 2012
Hui Li, Zhang Xuan, Huang Xu Feng, Han Mei, Fernandez Francesca, Yu Yaqin, Sun ShiLong, Li Wenjun, Chen Da Chun, Xiu Mei Hong, Kosten Thomas R, Zhang Xiang Yang
Abstract excerpt
BACKGROUND: Numerous studies report dysfunctional dopaminergic and noradrenergic neurotransmission in the pathogenesis of schizophrenia. Dopamine beta-hydroxylase (DBH) is an intracellular enzyme catalyzing the conversion of dopamine to noradrenaline. Functional polymorphisms have been reported in the promoter region of DBH gene, including a 19 bp insertion/deletion polymorphism. The purpose of this study was to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
